Recent senatorial hearings reflect the move to convict UPFs (ultra-processed food) as the culprit responsible for society’s obesity and juvenile metabolic diseases “epidemics” while deflecting focus ...

Scientists found brainstem neurons that tell mice when to stop eating, offering insights for obesity treatments. Columbia ...

Coming soon: Drugs for weight loss have been used for a long time in practice, however recent developments prompted the need for this special edition. The goals of this collection are to discuss ...

Granted permanent U.S. residence, as demonstrated by the issuance of a permanent residence card, i.e., a "Green Card" Granted U.S. citizenship Granted status as a "protected person" under 8 U.S.C.

Obesity is estimated to affect more than one billion people worldwide. In the US, about 40 percent of adults have obesity, according to the US Centers for Disease Control and Prevention.

With government initiatives emphasizing stronger local connections and equitable hiring practices, in-person career expos are a powerful tool for forward-thinking companies. Far from being ...

Obesity affects 650 million people worldwide and significantly contributes to the development of cardiometabolic diseases and increases the risk of cancer. Guadalupe Sabio, head of the Organ Crosstalk ...

Europe's largest pharmaceutical firm, Novo Nordisk, revealed positive trial results for its next-generation obesity drug, amycretin, marking a major step in its competition within the increasingly ...

The trial investigated the safety, tolerability, pharmacokinetics, and proof-of-concept after once-weekly subcutaneous administrations of amycretin in 125 people with overweight or obesity. The trial ...

Sharing her experience with GLP-1 weight loss drugs, Oprah reveals on the podcast, "One of the things that I realised the very first time I took a GLP-1 was that all these years, I thought that ...

This can result in misdiagnosis, with negative consequences for people living with obesity. A secondary analysis of trends of prevalence, patterns, and predictors from 2005 to 2020 using the ...